Moreover, the decreased expression of BRCA1 caused genome-wide EZH2 re-targeting and elevated H3K27me3 levels at PRC2 target loci in both mouse embryonic stem (ES) and human MCF7 BC cells. Here, EZH2 is linked to breast cancer.